These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6162051)

  • 1. [The clinical effect of chlormadinone acetate on carcinoma of the prostate (author's transl)].
    Matsuoka M; Mayuzumi T; Shida K
    Nihon Hinyokika Gakkai Zasshi; 1980 Sep; 71(9):1010-23. PubMed ID: 6162051
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of chlormadinone acetate therapy on the pituitary-testicular system in prostatic cancer].
    Nishimura R; Hosaka M; Mamiya N; Kimihira A; Konno M
    Horumon To Rinsho; 1977 Sep; 25(9):1013-8. PubMed ID: 72621
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hormonal environment following treatment with a small dose of estrogen--small dose of estrogen alone and in combination with an anti-androgen].
    Hayashi T; Taki Y; Ikai K; Hiura M; Kiriyama T
    Hinyokika Kiyo; 1987 Jul; 33(7):1035-42. PubMed ID: 2446483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment with chlormadinone acetate eliminates testosterone surge induced by a luteinizing-hormone-releasing hormone analogue and the risk of disease flare in patients with metastatic carcinoma of the prostate.
    Yoshida K; Takeuchi S
    Eur Urol; 1995; 27(3):187-91. PubMed ID: 7541358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of CMA in the treatment of prostatic cancer].
    Fukuoka H; Goto A; Murai T; Satomi Y; Moriyama M; Senga Y; Shirai K; Nakao H
    Hinyokika Kiyo; 1986 Dec; 32(12):1821-30. PubMed ID: 2435131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiandrogenic therapy for the treatment of early stage prostatic cancer.
    Nishimura R; Shida K
    Prostate Suppl; 1981; 1():27-34. PubMed ID: 6176981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hormone therapy of prostatic neoplasms].
    Frick J; Marberger H; Swoboda HP
    Urologe; 1971 May; 10(3):117-9. PubMed ID: 4104209
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of the carcinoma of the prostate with gestagens (author's transl)].
    Popelier G
    Urologe A; 1973 May; 12(3):134-9. PubMed ID: 4127418
    [No Abstract]   [Full Text] [Related]  

  • 9. Levels of serum follicle-stimulating hormone, luteinizing hormone, and plasma progestin during microdose chlormadinone treatment.
    Taymor ML; Levesque LA
    Fertil Steril; 1971 Jan; 22(1):1-8. PubMed ID: 4099041
    [No Abstract]   [Full Text] [Related]  

  • 10. Regression of prostatic hypertrophy by osaterone acetate in dogs.
    Tsutsu T; Hori T; Shimizu M; Orima H; Kawakami E; Fukuda S
    J Vet Med Sci; 2000 Oct; 62(10):1115-9. PubMed ID: 11073087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiologic basis for hormonal theapy in carcinoma of the prostate.
    Walsh PC
    Urol Clin North Am; 1975 Feb; 2(1):125-40. PubMed ID: 48206
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hormonal changes in carcinoma of the prostate].
    Rodrigues-Netto Júnior N; Da Silva RP; Hernández AJ
    Rev Paul Med; 1979; 94(1-2):24-6. PubMed ID: 120973
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of daily administration of 0.5 mg. of chlormadinone acetate on plasma levels of follicle-stimulating hormone, luteinizing hormone, and progesterone during the menstrual cycle.
    Saunders DM; Marcus SL; Saxena BB; Beling CG; Connell EB
    Fertil Steril; 1971 May; 22(5):332-44. PubMed ID: 4102481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of disease flare with diethylstilbestrol diphosphate and chlormadinone acetate administration for two weeks prior to slow-releasing leuprolide acetate in prostatic cancer patients.
    Ohuchi H; Noguchi K; Kinoshita Y; Hosaka M; Kawasaki C; Miura T; Kondo I; Harada M
    Hinyokika Kiyo; 2000 Aug; 46(8):531-6. PubMed ID: 11019371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Proceedings: Treatment of prostatic cancer with chlormadinone acetate. 1. The effect on testosterone dynamics].
    Nishimura R; Hosaka M; Mamiya N; Kimihira A; Konno M
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):510. PubMed ID: 4141674
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preventive effect of chlormadinone acetate on flare-up phenomenon in advanced prostate cancer administered with a luteinizing hormone-releasing hormone analogue].
    Sato N; Kotake T; Masai M; Sakai S; Ito H
    Hinyokika Kiyo; 2000 Jan; 46(1):1-7. PubMed ID: 10723656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [High-dose chlormadinone in the treatment of malignant tumors. An analysis of 20 cases (author's transl)].
    Chen YS; Zhang TJ; Zhang SS; Chen YX
    Zhonghua Zhong Liu Za Zhi; 1980 Dec; 2(4):288-91. PubMed ID: 6170502
    [No Abstract]   [Full Text] [Related]  

  • 18. Endocrine effects of cyproterone acetate in patients with prostatic cancer.
    Isurugi K; Fukutani K; Ishida H; Hosoi Y
    J Urol; 1980 Feb; 123(2):180-3. PubMed ID: 7354512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of orchidectomy, estrogens, and cyproterone acetate on plasma testosterone, LH, and FSH concentrations in patients with carcinoma of the prostate.
    Varenhorst E; Wallentin L; Carlström K
    Scand J Urol Nephrol; 1982; 16(1):31-6. PubMed ID: 6211762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlormadinone acetate pellet implantation plus short-term oral administration in dogs with benign prostatic hypertrophy.
    Kawakami E; Shimizu M; Orima H; Fujita M; Hori T; Tsutsui T
    Int J Androl; 1998 Apr; 21(2):67-73. PubMed ID: 9675615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.